Analysis of Risk Factors for Clopidogrel Resistance in Patients with CYP2C19 Intermediate Metabolic Coronary Heart Disease After PCI
WANG Shang
MAO Yun
ZHENG Lu
XU Ya-wei
YUAN Wei-teng
TANG Han
YANG Hai-bo
Machine-generated Keywords:
Publication Date:2020-10-25
Online Publishing Date:2026-09-12(First online date of this platform, not the publication date of the document)
Pages:4( 5578-5581 )
